MEK Inhibitor Therapy in Carcinomas With RAF1 Fusions: Inferior Response in a Patient With Pancreatic Acinar Cell Carcinoma
Christopher R McEvoy, Damien Kee, Owen WJ Prall, Timothy D Clay, Clare Scott, Anastasia Backhouse, Stephen B Fox, Andrew P Fellowes, Huiling Xu
JCO Precision Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2019
Awarded by Australian Genomic Health Alliance (National Health and Medical Research Council)
Supported by Melbourne Genomic Health Alliances and the Australian Genomic Health Alliance (National Health and Medical Research Council Grant No.1113531) and the Stafford Fox Medical Research Foundation for funding the Genomic Matching Treatment for Rare Cancers (NOMINATOR) study.